Ana E. Huerta

753 total citations
22 papers, 554 citations indexed

About

Ana E. Huerta is a scholar working on Physiology, Oncology and Biochemistry. According to data from OpenAlex, Ana E. Huerta has authored 22 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 6 papers in Oncology and 6 papers in Biochemistry. Recurrent topics in Ana E. Huerta's work include Biochemical Acid Research Studies (5 papers), Muscle metabolism and nutrition (4 papers) and Adipose Tissue and Metabolism (4 papers). Ana E. Huerta is often cited by papers focused on Biochemical Acid Research Studies (5 papers), Muscle metabolism and nutrition (4 papers) and Adipose Tissue and Metabolism (4 papers). Ana E. Huerta collaborates with scholars based in Spain, United States and Czechia. Ana E. Huerta's co-authors include J. Alfredo Martínéz, María J. Moreno‐Aliaga, Pedro L. Prieto‐Hontoria, Laura M. Laiglesia, Leyre Martínez‐Fernández, Óscar Beloqui, Santiago Navas‐Carretero, Neira Sáinź, Diego Martínez‐Urbistondo and Marta Fernández‐Galilea and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The FASEB Journal.

In The Last Decade

Ana E. Huerta

22 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana E. Huerta Spain 12 233 163 149 129 123 22 554
Marie‐Claude Lépine Canada 10 129 0.6× 220 1.3× 97 0.7× 145 1.1× 56 0.5× 13 501
Laurent L’homme Belgium 10 180 0.8× 70 0.4× 31 0.2× 338 2.6× 283 2.3× 14 688
Harrison M. Penrose United States 12 60 0.3× 39 0.2× 55 0.4× 220 1.7× 62 0.5× 22 473
Martina Mihalj Croatia 13 92 0.4× 134 0.8× 31 0.2× 88 0.7× 50 0.4× 42 488
Xue Geng China 12 71 0.3× 59 0.4× 45 0.3× 324 2.5× 53 0.4× 34 613
Jennifer Taher Canada 16 131 0.6× 39 0.2× 21 0.1× 174 1.3× 107 0.9× 36 562
Kerry Schwichtenberg United States 10 112 0.5× 223 1.4× 108 0.7× 140 1.1× 30 0.2× 16 705
Júlio C Fraulob-Aquino Canada 9 185 0.8× 115 0.7× 16 0.1× 122 0.9× 142 1.2× 12 544
Debora Donnini Italy 11 146 0.6× 27 0.2× 56 0.4× 126 1.0× 416 3.4× 23 720
Judith Chezar Israel 12 120 0.5× 58 0.4× 16 0.1× 120 0.9× 97 0.8× 22 611

Countries citing papers authored by Ana E. Huerta

Since Specialization
Citations

This map shows the geographic impact of Ana E. Huerta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana E. Huerta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana E. Huerta more than expected).

Fields of papers citing papers by Ana E. Huerta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana E. Huerta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana E. Huerta. The network helps show where Ana E. Huerta may publish in the future.

Co-authorship network of co-authors of Ana E. Huerta

This figure shows the co-authorship network connecting the top 25 collaborators of Ana E. Huerta. A scholar is included among the top collaborators of Ana E. Huerta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana E. Huerta. Ana E. Huerta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arasanz, Hugo, Ana E. Huerta, Natália Castro, et al.. (2025). CAR-T Therapy for the Treatment of Colorectal Cancer. Discovery Medicine. 37(195). 618–618. 1 indexed citations
2.
Labiano, Ibone, Ana E. Huerta, María Alsina, et al.. (2024). Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinoma. Scientific Reports. 14(1). 16203–16203. 4 indexed citations
3.
Alsina, María, Ana E. Huerta, Florian Lordick, et al.. (2024). Current practices and challenges in implementing precision medicine for upper gastrointestinal cancers in European academic centers: an EORTC survey. SHILAP Revista de lepidopterología. 5. 100074–100074. 1 indexed citations
4.
Martínez‐Urbistondo, Diego, Ana E. Huerta, David Navarro‐González, et al.. (2023). Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset. European Journal of Clinical Investigation. 53(10). e14036–e14036. 2 indexed citations
5.
Arasanz, Hugo, Luisa Chocarro, Leticia Fernández, et al.. (2023). Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer. International Journal of Molecular Sciences. 24(12). 9855–9855. 6 indexed citations
6.
Labiano, Ibone, Ana E. Huerta, Virginia Arrazubi, et al.. (2023). State of the Art: ctDNA in Upper Gastrointestinal Malignancies. Cancers. 15(5). 1379–1379. 8 indexed citations
7.
Alegre, Félix, et al.. (2021). Acquiring sepsis competencies through simulation-based learning bundle during intermediate care unit internship. Medicine. 100(5). e24483–e24483. 3 indexed citations
8.
Escoté, Xavier, Lucía Gayoso, Ana E. Huerta, et al.. (2018). Effects of EPA and lipoic acid supplementation on circulating FGF21 and the fatty acid profile in overweight/obese women following a hypocaloric diet. Food & Function. 9(5). 3028–3036. 15 indexed citations
9.
Romo‐Hualde, Ana, Ana E. Huerta, Carlos J. González-Navarro, et al.. (2018). Untargeted metabolomic on urine samples after α-lipoic acid and/or eicosapentaenoic acid supplementation in healthy overweight/obese women. Lipids in Health and Disease. 17(1). 103–103. 16 indexed citations
10.
Huerta, Ana E., Pedro L. Prieto‐Hontoria, Neira Sáinź, J. Alfredo Martínéz, & María J. Moreno‐Aliaga. (2016). Supplementation with α-Lipoic Acid Alone or in Combination with Eicosapentaenoic Acid Modulates the Inflammatory Status of Healthy Overweight or Obese Women Consuming an Energy-Restricted Diet. Journal of Nutrition. 146(4). 889S–896S. 43 indexed citations
11.
Martínez‐Urbistondo, Diego, et al.. (2016). El índice neutrófilo/linfocito como marcador de disfunción sistémica endotelial en sujetos asintomáticos. Nefrología. 36(4). 397–403. 33 indexed citations
12.
Martínez‐Urbistondo, Diego, et al.. (2016). The neutrophil–lymphocyte ratio as a marker of systemic endothelial dysfunction in asymptomatic subjects. Nefrología (English Edition). 36(4). 397–403. 27 indexed citations
13.
Huerta, Ana E., Pedro L. Prieto‐Hontoria, Marta Fernández‐Galilea, et al.. (2016). Effects of dietary supplementation with EPA and/or α‐lipoic acid on adipose tissue transcriptomic profile of healthy overweight/obese women following a hypocaloric diet. BioFactors. 43(1). 117–131. 20 indexed citations
14.
Huerta, Ana E., et al.. (2016). Afectación hepática en enfermedades sistémicas de patogenia inmunológica. Medicine - Programa de Formación Médica Continuada Acreditado. 12(10). 568–574. 1 indexed citations
15.
Huerta, Ana E., Pedro L. Prieto‐Hontoria, Marta Fernández‐Galilea, et al.. (2015). Circulating irisin and glucose metabolism in overweight/obese women: effects of α-lipoic acid and eicosapentaenoic acid. Journal of Physiology and Biochemistry. 71(3). 547–558. 50 indexed citations
16.
Martínez‐Fernández, Leyre, Laura M. Laiglesia, Ana E. Huerta, J. Alfredo Martínéz, & María J. Moreno‐Aliaga. (2015). Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome. Prostaglandins & Other Lipid Mediators. 121(Pt A). 24–41. 157 indexed citations
17.
Ravassa, Susana, Javier Beaumont, Ana E. Huerta, et al.. (2015). Association of low GLP-1 with oxidative stress is related to cardiac disease and outcome in patients with type 2 diabetes mellitus: A pilot study. Free Radical Biology and Medicine. 81. 1–12. 28 indexed citations
18.
Huerta, Ana E., Begoña López, Susana Ravassa, et al.. (2015). Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients. Journal of Hypertension. 34(1). 130–138. 27 indexed citations
19.
Huerta, Ana E., Santiago Navas‐Carretero, Pedro L. Prieto‐Hontoria, J. Alfredo Martínéz, & María J. Moreno‐Aliaga. (2014). Effects of α-lipoic acid and eicosapentaenoic acid in overweight and obese women during weight loss. Obesity. 23(2). 313–321. 90 indexed citations
20.
Landecho, Manuel F., Inmaculada Colina, Ana E. Huerta, et al.. (2011). Relación entre las fases precoces de la enfermedad renal y el síndrome metabólico. Revista Española de Cardiología. 64(5). 373–378. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie‐Claude Lépine Breakdown of academic impact, for papers by Laurent L’homme Breakdown of academic impact, for papers by Harrison M. Penrose Breakdown of academic impact, for papers by Martina Mihalj Breakdown of academic impact, for papers by Xue Geng Breakdown of academic impact, for papers by Jennifer Taher Breakdown of academic impact, for papers by Kerry Schwichtenberg Breakdown of academic impact, for papers by Júlio C Fraulob-Aquino Breakdown of academic impact, for papers by Debora Donnini Breakdown of academic impact, for papers by Judith Chezar
Rankless by CCL
2026